GSA Capital Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

GSA Capital Partners’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,144	Closed	-$241K	–	1314
2020 Q1	$241K	Buy	+5,144	New	+$330K	0.06%	635
2018 Q4	–	Sell	-4,474	Closed	-$292K	–	1913
2018 Q3	$292K	Buy	+4,474	New	+$263K	0.02%	1335
2018 Q2	–	Sell	-5,900	Closed	-$288K	–	2047
2018 Q1	$288K	Buy	+5,900	New	+$307K	0.02%	1324
2017 Q4	–	Sell	-34,500	Closed	-$1.48M	–	1927
2017 Q3	$1.48M	Buy	+34,500	New	+$1.1M	0.1%	291

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

GSA Capital Partners's MYOK Position: Q2 2020 in Review

GSA Capital Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 5,144 shares — an estimated $241K sold.

GSA Capital Partners first reported a position in MYOK in Q3 2017 and held it in 4 quarters. The position peaked at $1.48M in Q3 2017. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

GSA Capital Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
GSA Capital Partners sold 5,144 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $241K.
GSA Capital Partners first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
GSA Capital Partners's MyoKardia, Inc. Common Stock position peaked at $1.48M in Q3 2017.
235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on GSA Capital Partners's 13F filing for Q2 2020, filed 11 Aug 2020.